Trial record 1 of 57 for:    leptin and type 1 diabetes
Previous Study | Return to List | Next Study

Effects of Metreleptin in Type 1 Diabetes Mellitus

This study has been terminated.
(Sponsor request)
Sponsor:
Collaborators:
Juvenile Diabetes Research Foundation
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT01268644
First received: December 29, 2010
Last updated: June 22, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2014
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)